Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Autoimmune Disease Diagnostics Market By Type, By Disease, By End user and Geography
Autoimmune Disease Diagnostics Market By Type, By Disease, By End user and Geography
Autoimmune Disease Diagnostics Market size was valued at US$ 4.2 billion in 2022 and is anticipated to grow at US$ 6.4 billion till 2029 recording a CAGR of 8.9% during the forecast period 2023-2029. The immune system protects the body from infections and diseases. In autoimmune disorders, low or overactivity of the immune system may appear. There is no exact cause of autoimmune diseases is identified. In response to an unknown trigger, the immune system produces antibodies that instead of fighting infections, attack the body's own tissues. Autoimmune diseases are diagnosed with blood tests and a review of disease history, symptoms, and physical examination. Rheumatoid arthritis, type-1 diabetes, multiple sclerosis, and lupus are some of the major autoimmune diseases. The global autoimmune disease diagnostics market is expected to grow at a significant rate owing to growing rates of autoimmune diseases. According to the National Multiple Sclerosis Society (MS), approximately, 2.3 Mn people are living with multiple sclerosis worldwide. The market is composed of multinational and local companies involved in offering autoimmune diagnostics. Major players are involved in R&D for the development and introduction of new diagnostics into the market. Market players are collaborating in order to develop new diagnostics for autoimmune diseases and further increase the market portfolio. For instance, in November 2014, Protagen AG entered into a long-term collaboration with Qiagen to develop an innovative companion diagnostic development platform for autoimmune disorders. Furthermore, government and non-profit organizations are taking initiatives to increase awareness and involving in development of diagnostics for autoimmune diseases.
Autoimmune Disease Diagnostics Market Key Developments:
In November 2016, the U.S. FDA cleared Inova Diagnostic's assay, QUANTA LITE Calprotectin Extended Range to help differentiate inflammatory bowel disease from irritating bowel disease. In November 2014, Adaptive Biotechnologies launched, immunoSEQ, a research use only kit for diagnosing autoimmune.
Study Period
2025-2031Base Year
2024CAGR
8.9%Largest Market
North-AmericaFastest Growing Market
Europe
Global market is driven by government initiatives towards increasing awareness in public about autoimmune disorders. In addition, increase in R&D investments and rising prevalence of autoimmune disorders are expected to boost the global autoimmune disease diagnostics market. However, high cost of diagnosis, limited awareness in developing and underdeveloped countries are expected to hinder the market growth. In addition, chances of false results coupled with lack of skilled professionals are expected to hamper the global autoimmune disease diagnostics market over the forecast period.
Geographically, global market is segmented into following regions, viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is expected to be major market for autoimmune disease diagnostics owing to increase in prevalence of autoimmune disorders, presence of many market players, and government initiatives to promote the autoimmune disease awareness. Europe is expected to expand at significant growth rate for global autoimmune disease diagnostics due to growing awareness and rising prevalence of autoimmune diseases. Asia-Pacific is expected to grow at faster rates owing to expansion of MNC’s into the developing countries of the region such as India.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2022 |
US$ 4.2 billion |
|
Market CAGR |
8.9% |
|
By Type |
|
|
disease |
|
|
By End-user |
|
Download Free Sample Report
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Table of Content 2. Executive Summary 3. Global Autoimmune Disease Diagnostics Market Introduction 3.1. Global Autoimmune Disease Diagnostics Market – Taxonomy 3.2. Global Autoimmune Disease Diagnostics Market –Definitions 3.2.1. Type 3.2.2. Disease 3.2.3. End User 4. Global Autoimmune Disease Diagnostics Market Dynamics 4.1. Drivers 4.2. Restraints 4.3. Opportunities/Unmet Needs of the Market 4.4. Trends 4.5. Global Autoimmune Disease Diagnostics Market Dynamic Factors - Impact Analysis 4.6. Global Autoimmune Disease Diagnostics Market – Competition Landscape 4.7. Epidemiology 5. Global Autoimmune Disease Diagnostics Market Analysis,2015 - 2019 and Forecast, 2020 – 2026 5.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 5.3. Market OpportunityAnalysis 6. Global Autoimmune Disease Diagnostics Market, By Type, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1. Systemic Autoimmune Disease 6.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.1.3. Market Opportunity Analysis 6.2. Local Autoimmune Disease 6.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 6.2.3. Market Opportunity Analysis 7. Global Autoimmune Disease Diagnostics Market Forecast, By Disease,2015 - 2019 and Forecast, 2020 – 2026 7.1. Diabetes Type-1 7.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.1.3. Market Opportunity Analysis 7.2. Rheumatoid Arthritis 7.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.2.3. Market Opportunity Analysis 7.3. Multiple Sclerosis 7.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.3.3. Market Opportunity Analysis 7.4. Others 7.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 7.4.3. Market Opportunity Analysis 8. Global Autoimmune Disease Diagnostics Market Forecast, By End User, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 8.1. Diagnostic Centers 8.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.1.3. Market Opportunity Analysis 8.2. Hospitals 8.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.2.3. Market Opportunity Analysis 8.3. Research Laboratories 8.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.3.3. Market Opportunity Analysis 8.4. Others 8.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 8.4.3. Market Opportunity Analysis 9. Global Autoimmune Disease Diagnostics Market Forecast, By Region, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.1. North America 9.1.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.1.3. Market Opportunity Analysis 9.2. Europe 9.2.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.2.3. Market Opportunity Analysis 9.3. Asia-Pacific 9.3.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.3.3. Market Opportunity Analysis 9.4. Latin America 9.4.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.4.3. Market Opportunity Analysis 9.5. Middle East and Africa 9.5.1. Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 9.5.3. Market Opportunity Analysis 9.6. Global Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Region, 2020 – 2026 10. North America Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 10.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 10.1.1. Systemic Autoimmune Disease 10.1.2. Local Autoimmune Disease 10.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.2.1. Diabetes Type-1 10.2.2. Rheumatoid Arthritis 10.2.3. Multiple Sclerosis 10.2.4. Others 10.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.3.1. Diagnostic Centers 10.3.2. Hospitals 10.3.3. Research Laboratories 10.3.4. Others 10.4. Country Analysis 2016 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 10.4.1. U.S. 10.4.2. Canada 10.5. North America Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026 10.6. North America Autoimmune Disease Diagnostics Market Dynamics – Trends 11. Europe Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 11.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 11.1.1. Systemic Autoimmune Disease 11.1.2. Local Autoimmune Disease 11.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.2.1. Diabetes Type-1 11.2.2. Rheumatoid Arthritis 11.2.3. Multiple Sclerosis 11.2.4. Others 11.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.3.1. Diagnostic Centers 11.3.2. Hospitals 11.3.3. Research Laboratories 11.3.4. Others 11.4. Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 11.4.1. Germany 11.4.2. UK 11.4.3. France 11.4.4. Spain 11.4.5. Italy 11.4.6. Russia 11.4.7. Poland 11.4.8. Rest of Europe 11.5. Europe Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026 11.6. Europe Autoimmune Disease Diagnostics Market Dynamics – Trends 12. Asia-Pacific Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 12.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 12.1.1. Systemic Autoimmune Disease 12.1.2. Local Autoimmune Disease 12.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.2.1. Diabetes Type-1 12.2.2. Rheumatoid Arthritis 12.2.3. Multiple Sclerosis 12.2.4. Others 12.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.3.1. Diagnostic Centers 12.3.2. Hospitals 12.3.3. Research Laboratories 12.3.4. Others 12.4. Country Analysis2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 12.4.1. Japan 12.4.2. China 12.4.3. India 12.4.4. ASEAN 12.4.5. Australia & New Zealand 12.4.6. Rest of Asia-Pacific 12.5. Asia-Pacific Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026 12.6. Asia-Pacific Autoimmune Disease Diagnostics Market Dynamics – Trends 13. Latin America Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 13.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 13.1.1. Systemic Autoimmune Disease 13.1.2. Local Autoimmune Disease 13.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.2.1. Diabetes Type-1 13.2.2. Rheumatoid Arthritis 13.2.3. Multiple Sclerosis 13.2.4. Others 13.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 13.3.1. Diagnostic Centers 13.3.2. Hospitals 13.3.3. Research Laboratories 13.3.4. Others 13.4. Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 13.4.1. Brazil 13.4.2. Mexico 13.4.3. Argentina 13.4.4. Venezuela 13.4.5. Rest of Latin America 13.5. Latin America Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026 13.6. Latin America Autoimmune Disease Diagnostics Market Dynamics – Trends 14. Middle East and Africa Autoimmune Disease Diagnostics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026 (Revenue, USD Mn) 14.1. Type Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) 14.1.1. Systemic Autoimmune Disease 14.1.2. Local Autoimmune Disease 14.2. Disease Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.2.1. Diabetes Type-1 14.2.2. Rheumatoid Arthritis 14.2.3. Multiple Sclerosis 14.2.4. Others 14.3. End User Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 14.3.1. Diagnostic Centers 14.3.2. Hospitals 14.3.3. Research Laboratories 14.3.4. Others 14.4. Country Analysis 2015 - 2019 and Forecast 2020 - 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 14.4.1. Gulf Cooperation Council (GCC) Countries 14.4.2. Israel 14.4.3. South Africa 14.4.4. Rest of MEA 14.5. MEA Autoimmune Disease Diagnostics Market - Opportunity Analysis Index, By Type, By Disease, By End User and Country, 2020 – 2026 14.6. MEA Autoimmune Disease Diagnostics Market Dynamics – Trends 15. Competition Landscape 15.1. Strategic Dashboard of Top Market Players 15.2. Company Profiles (Introduction, Financial Analysis, Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) 15.2.1. Beckman Coulter, Inc. (U.S.) 15.2.2. Abbott Laboratories (U.S.) 15.2.3. F. Hoffmann-La Roche Ltd. (Switzerland) 15.2.4. bioMerieux SA (France) 15.2.5. Siemens AG (Siemens Healthineers) (Germany) 15.2.6. Inova Diagnostics Inc. (Werfen Life Group, S.A.(Spain) 15.2.7. Bio-Rad Laboratories (U.S.) 15.2.8. MBL International Corporation (U.S.) 15.2.9. Quest Diagnostics Inc. (U.S.). 16. Research Methodology 17. Key Assumptions and Acronyms 18. Disclaimer 19. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.